Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	117.06	34.1	32.4	12.59	36.83	45
Short-Term Investments	86.83	73.53	50.57	107.92	-	-
Cash & Short-Term Investments	203.89	107.62	82.97	120.51	36.83	45
Cash Growth	193.38%	29.71%	-31.15%	227.21%	-18.16%	-21.48%
Other Receivables	0.83	0.53	0.49	-	-	-
Receivables	0.83	0.53	0.49	-	-	-
Prepaid Expenses	1.77	0.94	3.62	0.8	0.89	1
Other Current Assets	0.74	0.34	0.47	1.31	0.24	0.27
Total Current Assets	207.23	109.43	87.55	122.62	37.96	46.27
Property, Plant & Equipment	1.04	1.23	1.56	0.19	0.18	0.33
Other Long-Term Assets	0.07	0.24	0.3	0.21	0.33	0.53
Total Assets	208.34	110.9	89.4	123.02	38.48	47.13
Accounts Payable	2.97	3.41	1.81	2.86	2.85	2.02
Accrued Expenses	5.98	6.81	3.71	3.52	3.81	3.43
Current Portion of Long-Term Debt	-	-	-	7	5.95	-
Current Portion of Leases	0.29	0.29	0.31	0.03	0.12	0.11
Total Current Liabilities	9.24	10.51	5.82	13.4	12.72	5.56
Long-Term Debt	-	-	-	2.15	8.65	13.95
Long-Term Leases	0.61	0.75	1.03	0	0.02	0.14
Other Long-Term Liabilities	-	-	-	0	-	0.2
Total Liabilities	9.85	11.26	6.86	15.56	21.4	19.85
Common Stock	0.12	0.09	0.07	0.06	0.03	0.02
Additional Paid-In Capital	508.03	386.53	321.64	317.59	197.96	174.24
Retained Earnings	-309.69	-287.05	-239.13	-210.07	-180.92	-146.98
Comprehensive Income & Other	0.02	0.06	-0.03	-0.12	-	-
Total Common Equity	198.49	99.64	82.55	107.46	17.08	27.28
Shareholders' Equity	198.49	99.64	82.55	107.46	17.08	27.28
Total Liabilities & Equity	208.34	110.9	89.4	123.02	38.48	47.13
Total Debt	0.89	1.03	1.34	9.18	14.74	14.21
Net Cash (Debt)	202.99	106.59	81.63	111.33	22.09	30.79
Net Cash Growth	197.20%	30.57%	-26.68%	404.06%	-28.27%	-45.94%
Net Cash Per Share	1.78	1.05	0.82	1.72	0.97	1.70
Filing Date Shares Outstanding	121.78	96.68	68.96	60.05	30.81	19.91
Total Common Shares Outstanding	121.78	93.6	68.28	59.94	28.51	18.55
Working Capital	197.99	98.92	81.72	109.22	25.23	40.71
Book Value Per Share	1.63	1.06	1.21	1.79	0.60	1.47
Tangible Book Value	198.49	99.64	82.55	107.46	17.08	27.28
Tangible Book Value Per Share	1.63	1.06	1.21	1.79	0.60	1.47
Machinery	-	0.35	0.3	0.21	0.11	0.11
Construction In Progress	-	0.01	0.02	0.05	-	-
Leasehold Improvements	-	0.03	0.03	0.13	0.13	0.13

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q